Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

Clinical trial NCT04494386 · COMPLETED

Trial details

NCT number: NCT04494386
Sponsor: Restem, LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Covid19 Corona Virus Infection SARS-CoV Infection ARDS Coronavirus

Start date: 2020-12-23
Primary completion: 2023-05-12
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.